1. Home/
  2. Compounds/
  3. navitoclax:gemcitabine (1:1 mol/mol)

navitoclax:gemcitabine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:gemcitabine (1:1 mol/mol)
PharmacoGx navitoclax:gemcitabine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:gemcitabine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CBX5 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA DOT1L CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA CD151 CTRPv2 pan-cancer AAC -0.21 4e-07
mRNA SLC39A13 CTRPv2 pan-cancer AAC -0.2 4e-07
mRNA ESPL1 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA SYNCRIP CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA TMED7-TICAM2 CTRPv2 pan-cancer AAC -0.2 4e-07
mRNA ANP32A CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA CTD-2369P2.12 CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA ARHGAP19 CTRPv2 pan-cancer AAC 0.21 5e-07
Download CSV